ABSTRACT:
Simple sensitive and accurate extractive spectrophotometric methods have developed for the estimation of Imatinib mesylate in pharmaceutical dosage form. The methods are based on the formation of coloured complexes by the drug with reagents like bromophenol blue, solochrome dark blue and bromocresol green in acidic medium. The ion associated complexes were formed and quantitatively extracted under the experimental condition in chloroform. The absorbance values were measured at 420 nm, 495 nm and 430 nm respectively. The proposed methods were validated statistically. Recoveries of methods were carried out by standard addition methods. The linearity was found to be 1-8 µg/ml, 2 -16µg/ml, 1-16 µg/ ml for methods 1, 2 and 3 respectively. The low values of standard deviation and percentage RSD indicate high precision of methods. Hence these methods are useful for routine estimation of Imatinib mesylate in tablets.
Cite this article:
Rajan V. Rele, Prathamesh P. Tiwatane. Estimation of Imatinib Mesylate by Extractive Colorimetric Methods in Bulk and Pharmaceutical Dosage Form. Asian Journal of Research in Chemistry. 2024; 17(3):145-8. doi: 10.52711/0974-4150.2024.00027
Cite(Electronic):
Rajan V. Rele, Prathamesh P. Tiwatane. Estimation of Imatinib Mesylate by Extractive Colorimetric Methods in Bulk and Pharmaceutical Dosage Form. Asian Journal of Research in Chemistry. 2024; 17(3):145-8. doi: 10.52711/0974-4150.2024.00027 Available on: https://www.ajrconline.org/AbstractView.aspx?PID=2024-17-3-4
REFERENCES:
1. B.V. Sreenivasulu and C Rambabu. New visible spectrophotometric assay of imatinib (β-form) in pure and formulations. International Journal of Pharmacy and Pharmaceutical Research. 2014; 2(1): 1-10.
2. Shereen. E. Abdel Karima, Raafat. A. Farghalya, Rasha. M. E-Nashar, Ashraf. H. Abadi. Spectrophotometric determination of imatinib mesylate using charge transfer complexes in pure form and pharmaceutical formulation. Chemical Rapid Communications. 2014; 2(3): 55-63.
3. MS. Patil Smita J., Doijad Rajendra C., Dhumal Priya P. Development of UV-spectrophotometric method for the determination of imatinib mesylate (itm) in bulk and formulation. Asian Journal of Pharmaceutical and Clinical Research. 2013; 6(3): 54-57.
4. M Akiful Haque, Vasudha Bakhshi, D Surekha, B Gouthami, C Hari Priya Reddy, B Yakamma. Development of UV-Spectrophotometric Method for the determination of Imatinib Mesylate (ITM) In Bulk and Formulation. International Journal of Pharma Research and Health Sciences. 2016; 4(2): 1130-1135.
5. Rajan V. Rele, Prathamesh P. Tiwatane. UV Spectrophotometric Estimation of Imatinib mesylate by Area under Curve Methods in Bulk and Pharmaceutical Dosage form. Asian J. Research Chem. 2019; 12(4): 213-216. DOI: 10.5958/0974-4150.2019.00040.3
6. Rajan V. Rele, Prathamesh P. Tiwatane. Derivative UV Spectrophotometric Method for Validation of Imatinib mesylate in Bulk and Pharmaceutical Dosage Form. Asian J. Research Chem. 2019; 12(5): 253-257. DOI: 10.5958/0974-4150.2019.00047.6
7. Fatma Ghrib Aymen Chtioui, Taieb Saied and Nizar Bellakhal. Determination of Imatinib and its Genotoxic Impurities in Tablets. Biological Forum – An International Journal. 2015; 7(1): 1820-1827.
8. Rajan V. Rele, Prathamesh P. Tiwatane. Determination of Imatinib mesylate from Pharmaceutical Dosage Form by extractive ion pair complex colorimetric Method. Asian J. Research Chem. 2024; 17(2): 78-80. DOI: 10.52711/0974-4150.2024.00015
9. S. Naga Sindhu, Y Srinivasa Rao, T. Hemant Kumar and K. Vara Prasada Rao. Method development and validation of RP-HPLC method for estimation of imatinib mesylate in pure and pharmaceutical dosage form. Der Pharmacia Lettre. 2015; 7(3): 33-38.
10. Pratik Shah, Nisha Shah and Rutesh Shah. Method development and validation of a stability indicating RP-HPLC method for assay determination of imatinib in imatinib mesylate tablets dosage form. International Journal of Pharmaceutical Sciences and Research. 2015; 6 (10) 4453-4468.
11. P. Sandhya, P. Vishnu Priya, Shyamala, N. Anjali Devi, JVC. Sharma. World Journal of Pharmacy and Pharmaceutical Sciences. 2013; 3(1): 682-688.
12. Pratik Shah, Rutesh Shah. A stability-indicating RP-HPLC method development and validation for the related substances determination of Imatinib process impurities and their degradation products in tablet dosage form. International Journal of Pharm Tech Research. 2015; 8(6): 128-146.
13. Arun Kumar Kuna, Ganapaty Seru, Gadela Venkata Radha. Analytical Method Development and Validation for the Estimation of Imatinib Mesylate and its Impurity in Pharmaceutical Formulation by RP-HPLC. International Journal of Pharmaceutical Sciences Review and Research. 2017; 42(2): 113-118.
14. Arun Kumar Kuna, Kuna Jagadeesh Kumar. RP-HPLC method development and validation of imatinib mesylate in tablet dosage form. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(5): 162-165.
15. Shaik Munwar Pasha, R. Vani. RP-HPLC Method development and validation for the estimation of imatinib mesylate and application to its dosage forms (tablets and capsules, Indo American Journal of Pharmaceutical Research. 2015; 5(10): 2015: 3140-3149.
16. Alagar Raja. M, Anusha. S, David Banji, Rao. K. N.V, Selva Kuamar. D. Analytical method development and validation of anticancer drugs (imatinib and cabacitabine) by RP-HPLC method. Asian Journal of Research in Chemistry and Pharmaceutical Sciences. 2015; 3(2): 51 – 65.
17. Farzana Hasin, Md. Towhidul Islam, Md. Forhad Ahmad, Md. Mahadi Hasan Rakib. Validation of assay method for the estimation of imatinib mesylate in tablet dosage form by HPLC. European Journal of Biomedical and Pharmaceutical Sciences. 2017; 4(7): 74-81.
18. Nalini Kanta Sahoo, Madhusmita Sahu, V Alagarsamy, B. Srividya and Chinmaya Keshari Sahoo. Validation of Assay Indicating Method Development of Imatinib in Bulk and Its Capsule Dosage Form by Liquid Chromatography. Ann Chromatogr Sep Tech. 2015; 1(2): 1-5.
19. Aleti p, Venisetty RK, Kamarapu SK. Development of RP-HPLC method for the analysis of imatinib mesylate using pda detector and its application in the evaluation of marketed preparation, International Journal of Pharmacy and Biological Sciences. 2011; 1(2): 14-18.
20. G. Sathwik1, Sonal Dubey, P. Prabitha and D. R. Harish Kumar. Analytical method development and validation of solid dosage form of antineoplastic drug imatinib mesylate by RP HPLC. International Journal of Pharma Sciences and Research. 2015; 6(4): 697-705.
21. Elisa Pirro, Silvia De Francia, Francesca De Martino, Carmen Fava, Stefano Ulisciani, Giovanna Rege Cambrin, Silvia Racca, Giuseppe Saglio, and Francesco Di Carlo. A new HPLC–UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. Journal of Chromatographic Science. 2011; 49: 753-757.
22. Rajan V. Rele, Sandip Patil. Development of Analytical Method by RP-HPLC Technique for Determination of Imatinib mesylate in Bulk Drug and Pharmaceutical Dosage Form. Asian J. Research Chem. 2019; 12(2): 79-83. DOI: 10.5958/0974-4150.2019.00018.X
23. Mahesh S. Wajurkar, Manjusha N. Dole. Development and validation of HPTLC method for determination of imatinib mesylate in API and tablet dosage form. Journal of Advanced Scientific Research. 2015; 6(3): 51-54.